Gütersloh – Arvato Systems is a new member of the German Association of Pharmaceutical Manufacturers (BAH). The BAH is considered the strongest trade association in Germany's pharmaceutical industry in terms of membership. As a provider of digital solutions in the pharmaceutical industry, Arvato Systems will now also be involved in the BAH's large partner network.
The important partnership with the industry association marks a milestone in Arvato Systems' market positioning and opens up new opportunities to once again expand its expertise in the pharmaceutical industry. Stefan Moch, Vice President Health at Arvato Systems, emphasizes: "We are extremely pleased to join the BAH and become part of this important network. As a provider of IT solutions for the pharmaceutical industry, we see this as an ideal opportunity to further strengthen our expertise in the digital transformation of pharmaceutical manufacturers and to address the challenges of the industry with our services."
As a member of the association, Arvato Systems can benefit from numerous advantages. The BAH offers a unique platform for exchanging ideas with the most important players in the pharmaceutical industry. These include pharmaceutical manufacturers, suppliers, market and opinion research institutes in the healthcare sector, as well as pharmacists, lawyers, publishers, and agencies. By working with this network, the IT specialist can deepen its understanding of the challenges and needs of the industry and target its solutions accordingly.
Arvato Systems has already proven itself as a reliable IT service provider in the pharmaceutical environment in the past. With solutions such as Arvato CSDB for the serialisation of pharmaceuticals, the platbricks® Healthcare Suite, and the operation of national verification systems in 17 EU countries, Arvato Systems has been able to win over a large number of customers. By joining the BAH, the company is looking forward to further impetus from the pharmaceutical sector to accompany the industry on its digitalization path in the long term.